The AstraZeneca PLC ADR AZN rose 1.25% to $68.81 Friday, on what proved to be an all-around positive trading session for the ...

AstraZeneca PLC closed 22.84% below its 52-week high of £133.88, which the company achieved on September 3rd.

(Reuters) -British equities closed higher on Friday, as the recent de-escalation of the global tariff war supported risk ...

Las acciones de las empresas farmacéuticas cayeron en todo el mundo después de que el presidente de EE.UU., Donald Trump, ...

Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US ...

AstraZeneca Plc lost its crown as the UK’s most valuable listed company after US President Donald Trump’s plans to lower drug ...

Mereo BioPharma Group plc’s MREO share price has dipped by 5.63%, which has investors questioning if this is right time to ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised ...

Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science ...

Below is Validea's guru fundamental report for ASTRAZENECA PLC (ADR) (AZN). Of the 22 guru strategies we follow, AZN rates highest using our P/E/Growth Investor model based on the published ...

President Donald Trump’s move to revive a policy that would slash Americans’ drug costs by tying them to lower prices paid ...

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in. The content of this article is provided for information ...